The global pharmaceutical CDMO (Contract Development and Manufacturing Organization) market was valued at USD 146.0 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% between 2024 and 2030. This growth is primarily driven by increasing investments in drug development by CDMOs and the rising demand for novel therapies. Other key contributors include...
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian